Have you or your loved ones been diagnosed with hemophilia a with inhibitors?

You may be eligible to participate in a hemophilia a with inhibitors clinical trial.

Have you or your loved ones been diagnosed with hemophilia a with inhibitors? You may be eligible to participate in a hemophilia a with inhibitors clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Hemophilia A With Inhibitors Clinical Trial in Aurora CO
NCT02448680 | Phase 3 | Interventional
LFB USA Inc
Sponsored by
LFB USA Inc

Have you or your loved ones been diagnosed with hemophilia a with inhibitors?

You may be eligible to participate in a hemophilia a with inhibitors clinical trial.

Have you or your loved ones been diagnosed with hemophilia a with inhibitors? You may be eligible to participate in a hemophilia a with inhibitors clinical trial.

Completed

Male

Up to 11

Years old

This study has recruited 25 Participants

The purpose of the study is to assess the safety, efficacy and pharmacokinetics of 2 separate dose regimens (75µg/kg and 225 µg/kg) of Coagulation Factor VIIa (Recombinant) for the treatment of bleeding episodes in hemophilia A or B patients with inhibitors to Factor VIII or IX in 12 patients ( birth to <6 years old), and 12 patients (≥6 years old to <12 years old).